Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027
Share
Why It Matters
Hemab started testing a new medicine in people for heavy bleeding. Watch for results by mid-2027 to see if it works safely.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.